Vera Health raises $28.5m Series A for clinical evidence search

Vera Health raises $28.5m Series A for clinical evidence search

27 October 2026: Vera Health, which answers clinicians' questions from medical literature and guidelines, says it has raised a $28.5 million Series A led by Threshold Ventures, with Mantis VC and SV Angel taking part. Existing investors Y Combinator and Gradient also invested again, bringing its total funding to $32 million.

Not yet independently verified. User numbers, country shares and the download ranking are Vera Health's own; the ranking cites Appark data we have not seen. Tech.eu names Optum Ventures as an investor but the company's announcement does not, so we leave it out. We will update this when it can be confirmed, and remove this note.

The company, based in San Francisco, says more than 800,000 clinicians now use it, up from a few thousand a year ago, and that it has reached 190 countries with a team of 12.

Growth that came mostly from Europe

The striking figure is where the users are. Vera Health says roughly one in four physicians in Spain and Italy and one in seven in France use it, mostly after hearing about it from a colleague. It also says it has been the most downloaded clinical app in the world across the App Store and Google Play every month since June, citing download data from Appark for June to September 2026.

Its two co-founders are Taieb Bennani and Maxime Allouch. "Clinicians are the best data scientists I've ever met," says Bennani. "They make the call in seconds, with more evidence than any human could ever read." He says everyone on the team is a clinician or the child or sibling of one.

Showing how strong the evidence is

The product's main claim is that it is built to say when the evidence is thin. It searches more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, finds the evidence first and then writes the answer, linking each claim to its source and grading it by strength.

"Unlike other tools, we believe there's value in making uncertainty visible," says Allouch. Through a partnership with the American College of Emergency Physicians (ACEP), the platform includes ACEP's clinical policies with source attribution. Tech.eu, which reported the round the same day, says the service is HIPAA and GDPR compliant and SOC 2 Type II certified.

Free for clinicians, funded by investors

Vera Health says it will stay free for licensed clinicians and medical trainees worldwide. The money will go on its clinical evidence infrastructure, expansion into more healthcare markets, and deeper partnerships with medical societies, publishers and health systems. The announcement does not say how the company plans to earn revenue, which is the open question for a free tool with this many users.

Hospitals weighing it against other clinical decision tools will want to know how it handles patient data typed into a query, and whether its answers are logged. Our catalogue lists 5 products in electronic medical records software and 7 in medical practice management software, but none yet in clinical evidence search.

Company profile on TrustList: Vera Health

Related on TrustList:

• Maggioli Group takes 20% of Turin clinical AI start-up DatAIMed
• CERT Polska lists 11 CGM CLININET flaws, several still unfixed
• Agora Labs raises EUR 4.3m to open hospital data to research

Sources

• Vera Health: Vera Health quietly became one of the world's most used clinical tools. Now it has raised $32 million, 27 October 2026
• Tech.eu: From two doctors to 800,000 clinicians, Vera Health raises $28.5M, 27 October 2026